Measurement of Lung Water by Transpulmonary Thermodilution in Lung Transplanted Patients

Repeated measurements of lung water by single transpulmonary thermodilution during the first postoperative days following lung transplantation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mucoviscidosis Congenital, Hereditary, and Neonatal Diseases and Abnormalities Cystic Fibrosis Digestive System Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Lung Diseases Pancreatic Diseases Pulmonary Insufficiency Respiration Disorders Respiratory Insufficiency Respiratory Tract Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hopital Foch

Suresnes, 92150, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

double-lung transplanted patients

Exclusion criteria

none

Treatment and study plan

Double-lung transplantation

Procedure

Double-lung transplanted patients

Primary outcomes

extra-vascular lung water

Time frame: first postoperative days

Secondary outcomes

pulmonary permeability index

Time frame: first postoperative days

Sponsors and collaborators

Lead sponsor

Hopital Foch

Other

Registry information

Official study title

Interest of Repeated Extravascular Lung Water Measurements With the PICCO Device in Lung Transplanted Patients

Acronym: PICCO-LungT

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2011
First posted: Feb 3, 2009
Registry last updated: Sep 23, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed